Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cell Rising Capital is a Hong Kong-based venture capital firm that specializes in angel to series A funding for startups across Europe and Asia. Founded to facilitate cross-continental connections, the firm emphasizes the exchange of innovative technologies between these regions. It targets early-stage companies in various sectors, including AI, biotech, and fintech.
Cell Rising Capital invests in sectors such as advanced manufacturing, artificial intelligence, biotechnology, electric vehicles, financial technology, medical technology, and sustainability. The firm specifically targets startups in the early stages of development, from angel to series A funding, to support their growth and technological advancements.
Notable projects associated with Cell Rising Capital include Hex Trust, which secured strategic investment from Morgan Creek; Wrisk, which raised £12 million for reengineering automotive insurance; and audioXpress, a collaboration between Audioscenic and AIStorm to deliver cost-effective position-sensing 3D sound.
Submit through their form at cellrising.com or email info@cellrising.com with your deck.
Yes, Cell Rising Capital often leads funding rounds, particularly in the angel and seed stages, to provide startups with the necessary capital and support.
The firm is open to follow-on investments, especially for startups that demonstrate significant growth potential and align with their investment thesis.
Specific details about the size of Cell Rising Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.